Hexacima suspension for injection
- Licence status
- Active substances
- Haemophilus influenzae type b capsular polysaccharide, Pertussis toxoid, (polyribosylribitol phosphate) conjugated to tetanous protein, Filamentous haemagglutinin, Type 1 (mahoney), Diphtheria toxoid, Type 2 (mef-1), Tetanus toxoid, Type 3 (saukett), Hepatitis b surface antigen
- Dosage Form
- Suspension for injection
- Licence number
- EU/1/13/828/001-007
- Licence holder
- Sanofi Winthrop Industrie
Product documents
Licence information
- ATC code
- J07CA Bacterial and viral vaccines, combined, J07CA09 diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 17/04/2013